Hong, Xiaonan
Song, Yuqin
Huang, Huiqiang
Bai, Bing
Zhang, Huilai
Ke, Xiaoyan
Shi, Yuankai
Zhu, Jun
Lu, Guodong
Liebscher, Stefan
Cai, Chunxiao
Clinical trials referenced in this document:
Documents that mention this clinical trial
Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study
https://doi.org/10.1007/s11523-019-00630-y
Funding for this research was provided by:
Mundipharma (China) Pharmaceutical Co., Ltd
Article History
First Online: 23 March 2019
Compliance with Ethical Standards
:
: This study was funded by Mundipharma (China) Pharmaceutical Co., Ltd. Open Access publication of this article was funded by Mundipharma (China) Pharmaceutical Co., Ltd.
: Stefan Liebscher was an employee of Mundipharma Research GmbH at the time the study was conducted. Guodong Lu and Chunxiao Cai are employees of Mundipharma (China) Pharmaceutical Co., Ltd. Xiaonan Hong, Yuqin Song, Huiqiang Huang, Bing Bai, Huilai Zhang, Xiaoyan Ke, Yuankai Shi, and Jun Zhu declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.